Table 3 –
Mean baseline ± Std. Dev. (N = 16) | Mean 3 mo ± Std. Dev. (N = 16) | Mean difference (95% CI) |
P value | |
---|---|---|---|---|
FACT-G | 82.2 ± 17.8 | 82.8 ± 17.5 | 0.6 (−5.2, 6.3) | 0.84 |
PWB | 21.0 ± 6.8 | 21.6 ± 6.2 | 0.6 (−1.6, 2.7) | 0.59 |
SWB | 22.9 ± 4.5 | 23.9 ± 5.3 | 1.1 (−0.5, 2.7) | 0.18 |
EWB | 18.1 ± 4.0 | 17.8 ± 5.2 | −0.4 (−2.2, 1.5) | 0.67 |
FWB | 20.1 ± 7.1 | 19.4 ± 7.0 | −0.7 (−3.1, 1.7) | 0.56 |
FKSI | 44.4 ± 10.6 | 46.2 ± 9.1 | 1.8 (−1.6, 5.1) | 0.28 |
EQ-5D-5L Health scale | 68.9 ± 22.2 | 73.9 ± 11.9 | 5.0 (−5.9, 15.9) | 0.34 |
EQ-5D-5L = EuroQol Group’s five-level; EWB = emotional well-being; FACT-G = Functional Assessment of Cancer Therapy—General; FKSI = Functional Assessment of Cancer Therapy Kidney Cancer Symptom Index; FWB = functional well-being; PWB = physical well-being; sWb = social well-being.